Ghent University Academic Bibliography

Your filters: cql: author="Mannent, Leda P." or (type any "bookEditor issueEditor" and editor="Mannent, Leda P.")

Add to list
- Journal Article
- A1
- open access
Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Chien‐Chia Chuang, Isabelle Guillemin, Claus Bachert (UGent) , Stella E. Lee, Peter Hellings (UGent) , Wytske J. Fokkens, Nicolas Duverger, Chunpeng Fan, Nadia Daizadeh, Nikhil Amin, et al.

(2022) LARYNGOSCOPE. 132(2). p.259-264
Add to list
- Journal Article
- A1
- open access
Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert (UGent) , Leda P. Mannent, G. Walter Canonica, Joseph K. Han, Jorge F. Maspero, Cesar Picado, Nadia Daizadeh, Benjamin Ortiz, et al.

(2022) ALLERGY. 77(4). p.1231-1244
Add to list
- Journal Article
- A1
- open access
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status

Shigeharu Fujieda, Shoji Matsune, Sachio Takeno, Nobuo Ohta, Mikiya Asako, Claus Bachert (UGent) , Tomoyuki Inoue, Yoshinori Takahashi, Hiroyuki Fujita, Yamo Deniz, et al.

(2022) ALLERGY. 77(1). p.186-196
Add to list
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Joaquim Mullol, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter W Hellings, Joseph K Han, Roger Jankowski, Jan Vodicka, Philippe Gevaert (UGent) , Nadia Daizadeh, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(4). p.1086-1095.e5
Add to list
- Journal Article
- A1
- open access
Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis

Joseph K. Han, Claus Bachert (UGent) , Stella E. Lee, Claire Hopkins, Enrico Heffler, Peter Hellings (UGent) , Anju T. Peters, Siddhesh Kamat, Diane Whalley, Shanshan Qin, et al.

(2022) LARYNGOSCOPE. 132(2). p.265-271
Add to list
- Journal Article
- A1
- open access
Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

G Walter Canonica, Arnaud Bourdin, Anju T Peters, Martin Desrosiers, Claus Bachert (UGent) , Stephan Weidinger, Eric L Simpson, Nadia Daizadeh, Zhen Chen, Siddesh Kamat, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(6). p.1515-1526
Add to list
- Journal Article
- A1
- open access
Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps

Anju T. Peters, Joseph K. Han, Peter Hellings (UGent) , Enrico Heffler, Philippe Gevaert (UGent) , Claus Bachert (UGent) , Yingxin Xu, Chien-Chia Chuang, Binod Neupane, Jérôme Msihid, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 9(6). p.2461-2471.e5
Add to list
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

Claire Hopkins, Martin Wagenmann, Claus Bachert (UGent) , Martin Desrosiers, Joseph K. Han, Peter W. Hellings, Stella E. Lee, Jerome Msihid, Amr Radwan, Paul Rowe, et al.

(2021) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 11(7). p.1087-1101
Add to list
- Journal Article
- A1
- open access
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

Tanya M. Laidlaw, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter Hellings (UGent) , Joaquim Mullol, Jorge F. Maspero, Philippe Gevaert (UGent) , Mei Zhang, Xuezhou Mao, et al.

(2021) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 126(5). p.584-592.e1
Add to list
- Journal Article
- A1
- open access
Dupilumab in children with uncontrolled moderate-to-severe asthma

Leonard B Bacharier, Jorge F Maspero, Constance H Katelaris, Alessandro G Fiocchi, Remi Gagnon, Ines de Mir, Neal Jain, Lawrence D Sher, Xuezhou Mao, D. Liu, et al.

(2021) NEW ENGLAND JOURNAL OF MEDICINE. 385(24). p.2230-2240

Academic Bibliography

Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status

Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis

Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps

Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

Dupilumab in children with uncontrolled moderate-to-severe asthma

Contents

Support

Contact